AFP and eGFR are related to early and late recurrence of HCC following antiviral therapy
T Watanabe, Y Tokumoto, K Joko, K Michitaka… - BMC cancer, 2021 - Springer
Background An unexpected recurrence of hepatocellular carcinoma (HCC) sometimes
occurs in patients with hepatitis C virus (HCV) after treatment with direct-acting antivirals …
occurs in patients with hepatitis C virus (HCV) after treatment with direct-acting antivirals …
Controversies of Direct-Acting Antivirals in Hepatocellular Carcinoma
Controversies of Direct-Acting Antivirals in Hepatocellular Carcinoma - Surgical Oncology
Clinics Skip to Main Content Advertisement Surgical Oncology Clinics Log in Register Log in …
Clinics Skip to Main Content Advertisement Surgical Oncology Clinics Log in Register Log in …
High efficacy of direct‐acting anti‐viral agents in hepatitis C virus‐infected cirrhotic patients with successfully treated hepatocellular carcinoma
Background The efficacy of direct‐acting anti‐viral (DAA) therapy in patients with a history of
hepatocellular carcinoma (HCC) is unknown. Aim We prospectively evaluated whether …
hepatocellular carcinoma (HCC) is unknown. Aim We prospectively evaluated whether …
Oncologic implications of chronic hepatitis C virus infection
JP Hwang, NK LoConte, JP Rice, LE Foxhall… - Journal of oncology …, 2019 - ascopubs.org
Chronic hepatitis C virus (HCV) infection increases the risk for several types of cancer,
including hepatocellular carcinoma (HCC) and B-cell non-Hodgkin lymphoma, as primary …
including hepatocellular carcinoma (HCC) and B-cell non-Hodgkin lymphoma, as primary …
Circulating exosomal miRNA profiles predict the occurrence and recurrence of hepatocellular carcinoma in patients with direct-acting antiviral-induced sustained viral …
S Itami-Matsumoto, M Hayakawa, S Uchida-Kobayashi… - Biomedicines, 2019 - mdpi.com
Direct-acting antiviral (DAA) therapy for chronic hepatitis C virus (HCV) infection patients
(CH) results in a sustained viral response (SVR) in over 95% of patients. However …
(CH) results in a sustained viral response (SVR) in over 95% of patients. However …
[HTML][HTML] Decreased risk of hepatocellular carcinoma recurrence with direct-acting antivirals compared with no treatment for hepatitis C: a meta-analysis
FH Lui, Z Moosvi, A Patel, S Hussain… - Annals of …, 2020 - ncbi.nlm.nih.gov
Background Studies investigating the association between direct-acting antivirals (DAAs)
and the recurrence of hepatocellular carcinoma (HCC) related to hepatitis C (HCV) have …
and the recurrence of hepatocellular carcinoma (HCC) related to hepatitis C (HCV) have …
Clinical outcomes of direct‐acting antiviral treatments for patients with hepatitis C after hepatocellular carcinoma are equivalent to interferon treatment
Y Tahata, R Sakamori, A Urabe, R Yamada… - Hepatology …, 2020 - Wiley Online Library
Aim It remains unclear how direct‐acting antiviral (DAA) treatments influence hepatocellular
carcinoma (HCC) recurrence and survival in comparison with interferon (IFN). Methods In …
carcinoma (HCC) recurrence and survival in comparison with interferon (IFN). Methods In …
Exploring the Impact of Different Inflammatory Cytokines on Hepatitis C Virus Infection
NG Bader El Din, S Farouk - Journal of Interferon & Cytokine …, 2024 - liebertpub.com
Hepatitis C virus (HCV) infection is a global health concern affecting millions worldwide.
Chronic HCV infection often leads to liver inflammation and can progress to cirrhosis and …
Chronic HCV infection often leads to liver inflammation and can progress to cirrhosis and …
Over time evaluation of glycaemic control in direct‐acting antiviral‐treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis
I Cacciola, G Russo, R Filomia, C Pitrone… - Liver …, 2021 - Wiley Online Library
Background Data concerning the impact of hepatitis C virus (HCV) cure on type 2 diabetes
mellitus (T2DM) are controversial. The aim of the study was to evaluate the effects of anti …
mellitus (T2DM) are controversial. The aim of the study was to evaluate the effects of anti …
Oral direct-acting antivirals and the incidence or recurrence of hepatocellular carcinoma: a systematic review and meta-analysis
S Singh, A Nautiyal, YK Loke - Frontline gastroenterology, 2018 - fg.bmj.com
Background The influence of direct-acting antiviral (DAA) therapy for chronic hepatitis C
virus on the risk of hepatocellular carcinoma (HCC) is conflicting. Methods We conducted a …
virus on the risk of hepatocellular carcinoma (HCC) is conflicting. Methods We conducted a …